Recombinant Mouse Myocilin Protein (Yeast)，His

Myocilin is a protein that plays a crucial role in ocular physiology and is primarily associated with the pathogenesis of glaucoma, a leading cause of irreversible blindness worldwide. The research surrounding myocilin has intensified due to its genetic mutations linked to primary open-angle glaucoma (POAG). These mutations often lead to abnormal protein folding and aggregation, resulting in increased intraocular pressure and degeneration of retinal ganglion cells. Recombinant myocilin proteins are essential for elucidating the molecular mechanisms underlying its function and the pathogenicity of the associated mutations. By producing myocilin in sufficient quantities through recombinant DNA technology, researchers can conduct in vitro studies to investigate its structure, biochemical properties, and interaction with other cellular components. Additionally, recombinant myocilin provides a platform for drug screening and the development of gene therapies aimed at correcting the underlying genetic defects. The growing understanding of myocilin's role in cellular homeostasis holds promise for novel therapeutic strategies to prevent or even treat glaucoma, thereby potentially reducing the burden of this prevalent ocular disease. Overall, the study of recombinant myocilin is pivotal in bridging the gap between basic research and clinical applications in the management of glaucoma.